<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib153">
 <element-citation publication-type="book" id="sref153">
  <person-group person-group-type="author">
   <name>
    <surname>Xu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Peng</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Shi</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Mu</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>W.</given-names>
   </name>
  </person-group>
  <chapter-title>Nelfinavir Was Predicted to Be a Potential Inhibitor of 2019-nCov Main Protease by an Integrative Approach Combining Homology Modelling, Molecular Docking and Binding Free Energy Calculation</chapter-title>
  <year>2020</year>
  <publisher-name>bioRxiv</publisher-name>
 </element-citation>
</ref>
